vs
康美(CNMD)与electroCore, Inc.(ECOR)财务数据对比。点击上方公司名可切换其他公司
康美的季度营收约是electroCore, Inc.的40.4倍($373.2M vs $9.2M)。electroCore, Inc.同比增速更快(31.2% vs 7.9%)。过去两年electroCore, Inc.的营收复合增速更高(30.3% vs 9.3%)
康美公司是一家上市的美国医疗设备制造商,主营骨科、腹腔镜、普通外科相关医疗器械以及各类患者护理产品,总部现位于佛罗里达州拉戈,2022年7月前设于纽约州尤蒂卡。该品牌秉持以人为本的文化,以助力医疗合作方及其服务的患者为核心使命,在美国和墨西哥都设有生产基地。
electroCore是一家总部位于美国新泽西州巴斯金里奇的医疗科技公司,于2005年由四位联合创始人创立,现任首席执行官为Daniel S. Goldberger。公司主打产品为gammaCore,是一款已实现商业化的非侵入式设备,通过迷走神经刺激发挥作用。
CNMD vs ECOR — 直观对比
营收规模更大
CNMD
是对方的40.4倍
$9.2M
营收增速更快
ECOR
高出23.3%
7.9%
两年增速更快
ECOR
近两年复合增速
9.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $373.2M | $9.2M |
| 净利润 | — | $-3.0M |
| 毛利率 | 58.5% | 88.4% |
| 营业利润率 | 9.8% | -31.8% |
| 净利率 | — | -32.8% |
| 营收同比 | 7.9% | 31.2% |
| 净利润同比 | — | 6.0% |
| 每股收益(稀释后) | $0.54 | $-0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CNMD
ECOR
| Q4 25 | $373.2M | $9.2M | ||
| Q3 25 | $337.9M | $8.7M | ||
| Q2 25 | $342.3M | $7.4M | ||
| Q1 25 | $321.3M | $6.7M | ||
| Q4 24 | $345.9M | $7.0M | ||
| Q3 24 | $316.7M | $6.6M | ||
| Q2 24 | $332.1M | $6.1M | ||
| Q1 24 | $312.3M | $5.4M |
净利润
CNMD
ECOR
| Q4 25 | — | $-3.0M | ||
| Q3 25 | $2.9M | $-3.4M | ||
| Q2 25 | $21.4M | $-3.7M | ||
| Q1 25 | $6.0M | $-3.9M | ||
| Q4 24 | — | $-3.2M | ||
| Q3 24 | $49.0M | $-2.5M | ||
| Q2 24 | $30.0M | $-2.7M | ||
| Q1 24 | $19.7M | $-3.5M |
毛利率
CNMD
ECOR
| Q4 25 | 58.5% | 88.4% | ||
| Q3 25 | 49.2% | 86.0% | ||
| Q2 25 | 55.0% | 87.3% | ||
| Q1 25 | 55.3% | 84.9% | ||
| Q4 24 | 57.3% | 85.9% | ||
| Q3 24 | 56.5% | 83.8% | ||
| Q2 24 | 55.3% | 86.3% | ||
| Q1 24 | 55.1% | 83.7% |
营业利润率
CNMD
ECOR
| Q4 25 | 9.8% | -31.8% | ||
| Q3 25 | 3.5% | -33.2% | ||
| Q2 25 | 11.1% | -47.5% | ||
| Q1 25 | 5.0% | -56.9% | ||
| Q4 24 | 15.2% | -43.6% | ||
| Q3 24 | 20.7% | -40.4% | ||
| Q2 24 | 14.2% | -42.2% | ||
| Q1 24 | 11.2% | -70.7% |
净利率
CNMD
ECOR
| Q4 25 | — | -32.8% | ||
| Q3 25 | 0.8% | -39.2% | ||
| Q2 25 | 6.3% | -49.7% | ||
| Q1 25 | 1.9% | -57.4% | ||
| Q4 24 | — | -45.8% | ||
| Q3 24 | 15.5% | -38.1% | ||
| Q2 24 | 9.0% | -43.2% | ||
| Q1 24 | 6.3% | -64.4% |
每股收益(稀释后)
CNMD
ECOR
| Q4 25 | $0.54 | $-0.34 | ||
| Q3 25 | $0.09 | $-0.40 | ||
| Q2 25 | $0.69 | $-0.44 | ||
| Q1 25 | $0.19 | $-0.47 | ||
| Q4 24 | $1.09 | $-0.37 | ||
| Q3 24 | $1.57 | $-0.31 | ||
| Q2 24 | $0.96 | $-0.38 | ||
| Q1 24 | $0.63 | $-0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $11.6M |
| 总债务越低越好 | $834.2M | $7.8M |
| 股东权益账面价值 | $1.0B | $-1.7M |
| 总资产 | $2.3B | $18.7M |
| 负债/权益比越低杠杆越低 | 0.81× | — |
8季度趋势,按日历期对齐
现金及短期投资
CNMD
ECOR
| Q4 25 | — | $11.6M | ||
| Q3 25 | — | $13.0M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $7.8M | ||
| Q4 24 | — | $12.2M | ||
| Q3 24 | — | $12.9M | ||
| Q2 24 | — | $14.2M | ||
| Q1 24 | — | $7.8M |
总债务
CNMD
ECOR
| Q4 25 | $834.2M | $7.8M | ||
| Q3 25 | $853.0M | $7.8M | ||
| Q2 25 | $881.1M | — | ||
| Q1 25 | $891.4M | — | ||
| Q4 24 | $905.1M | — | ||
| Q3 24 | $940.1M | — | ||
| Q2 24 | $965.2M | — | ||
| Q1 24 | $990.1M | — |
股东权益
CNMD
ECOR
| Q4 25 | $1.0B | $-1.7M | ||
| Q3 25 | $1.0B | $-1.1M | ||
| Q2 25 | $1.0B | $1.1M | ||
| Q1 25 | $977.6M | $4.4M | ||
| Q4 24 | $962.7M | $7.5M | ||
| Q3 24 | $932.9M | $9.5M | ||
| Q2 24 | $881.8M | $11.5M | ||
| Q1 24 | $854.7M | $4.5M |
总资产
CNMD
ECOR
| Q4 25 | $2.3B | $18.7M | ||
| Q3 25 | $2.3B | $21.4M | ||
| Q2 25 | $2.3B | $14.6M | ||
| Q1 25 | $2.3B | $16.0M | ||
| Q4 24 | $2.3B | $20.5M | ||
| Q3 24 | $2.3B | $21.0M | ||
| Q2 24 | $2.3B | $22.4M | ||
| Q1 24 | $2.3B | $13.9M |
负债/权益比
CNMD
ECOR
| Q4 25 | 0.81× | — | ||
| Q3 25 | 0.85× | — | ||
| Q2 25 | 0.88× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 1.01× | — | ||
| Q2 24 | 1.09× | — | ||
| Q1 24 | 1.16× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $46.3M | $-1.5M |
| 自由现金流经营现金流 - 资本支出 | $41.2M | — |
| 自由现金流率自由现金流/营收 | 11.0% | — |
| 资本支出强度资本支出/营收 | 1.4% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $150.9M | — |
8季度趋势,按日历期对齐
经营现金流
CNMD
ECOR
| Q4 25 | $46.3M | $-1.5M | ||
| Q3 25 | $53.7M | $-1.7M | ||
| Q2 25 | $29.1M | $-623.0K | ||
| Q1 25 | $41.5M | $-4.4M | ||
| Q4 24 | $43.3M | $-1.3M | ||
| Q3 24 | $51.2M | $-1.4M | ||
| Q2 24 | $43.3M | $-1.8M | ||
| Q1 24 | $29.1M | $-2.6M |
自由现金流
CNMD
ECOR
| Q4 25 | $41.2M | — | ||
| Q3 25 | $48.5M | $-1.7M | ||
| Q2 25 | $23.4M | $-648.0K | ||
| Q1 25 | $37.8M | $-4.4M | ||
| Q4 24 | $39.3M | — | ||
| Q3 24 | $47.8M | — | ||
| Q2 24 | $39.7M | — | ||
| Q1 24 | $27.1M | — |
自由现金流率
CNMD
ECOR
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.4% | -19.3% | ||
| Q2 25 | 6.8% | -8.8% | ||
| Q1 25 | 11.8% | -65.4% | ||
| Q4 24 | 11.4% | — | ||
| Q3 24 | 15.1% | — | ||
| Q2 24 | 12.0% | — | ||
| Q1 24 | 8.7% | — |
资本支出强度
CNMD
ECOR
| Q4 25 | 1.4% | 0.0% | ||
| Q3 25 | 1.5% | 0.0% | ||
| Q2 25 | 1.7% | 0.3% | ||
| Q1 25 | 1.2% | 0.6% | ||
| Q4 24 | 1.2% | — | ||
| Q3 24 | 1.1% | — | ||
| Q2 24 | 1.1% | — | ||
| Q1 24 | 0.7% | — |
现金转化率
CNMD
ECOR
| Q4 25 | — | — | ||
| Q3 25 | 18.78× | — | ||
| Q2 25 | 1.36× | — | ||
| Q1 25 | 6.88× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.05× | — | ||
| Q2 24 | 1.44× | — | ||
| Q1 24 | 1.48× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNMD
| Transferred At Point In Time | $358.5M | 96% |
| Transferred Over Time | $14.7M | 4% |
ECOR
暂无分部数据